A Study on the Potential of Active Constituent from Senna spectabilis in Treating Leishmania major Infection

Leishmaniasis affects millions of people each year. It consists of a group of tropical infections that are effecting human populations in mainly low-income countries. Visceral Leishmaniasis (VL) and Cutaneous Leishmaniasis (CL) are the main forms of Leishmaniasis which cause mortality, chronic disab...

Full description

Bibliographic Details
Main Author: IFNM, Institut Farmaseutikal & Nutraseutikal Malaysia
Format: Article
Language:English
Published: 2017
Subjects:
Online Access:http://eprints.usm.my/36440/
http://eprints.usm.my/36440/1/c1edc42e7ecc26b5078b32919cba765b.pdf
_version_ 1848877911481778176
author IFNM, Institut Farmaseutikal & Nutraseutikal Malaysia
author_facet IFNM, Institut Farmaseutikal & Nutraseutikal Malaysia
author_sort IFNM, Institut Farmaseutikal & Nutraseutikal Malaysia
building USM Institutional Repository
collection Online Access
description Leishmaniasis affects millions of people each year. It consists of a group of tropical infections that are effecting human populations in mainly low-income countries. Visceral Leishmaniasis (VL) and Cutaneous Leishmaniasis (CL) are the main forms of Leishmaniasis which cause mortality, chronic disability and poverty. Leishmanasis is among three of most neglected diseases in the world, together with Human African Trypanosomiasis (HAT) and Chagas’ disease. These diseases are termed as neglected diseases because they are receiving very limited press attention as well as research funding as compared to HIV/AIDS, tuberculosis and malaria. In 2003, Drugs for Neglected Diseases Initiative (DNDi) which is a non-profit drug R&D agency focusing on developing new treatments for neglected diseases was established
first_indexed 2025-11-15T17:22:58Z
format Article
id usm-36440
institution Universiti Sains Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T17:22:58Z
publishDate 2017
recordtype eprints
repository_type Digital Repository
spelling usm-364402017-09-11T09:59:00Z http://eprints.usm.my/36440/ A Study on the Potential of Active Constituent from Senna spectabilis in Treating Leishmania major Infection IFNM, Institut Farmaseutikal & Nutraseutikal Malaysia RM Therapeutics. Pharmacology RS Pharmacy and materia medica Leishmaniasis affects millions of people each year. It consists of a group of tropical infections that are effecting human populations in mainly low-income countries. Visceral Leishmaniasis (VL) and Cutaneous Leishmaniasis (CL) are the main forms of Leishmaniasis which cause mortality, chronic disability and poverty. Leishmanasis is among three of most neglected diseases in the world, together with Human African Trypanosomiasis (HAT) and Chagas’ disease. These diseases are termed as neglected diseases because they are receiving very limited press attention as well as research funding as compared to HIV/AIDS, tuberculosis and malaria. In 2003, Drugs for Neglected Diseases Initiative (DNDi) which is a non-profit drug R&D agency focusing on developing new treatments for neglected diseases was established 2017 Article PeerReviewed application/pdf en cc_by http://eprints.usm.my/36440/1/c1edc42e7ecc26b5078b32919cba765b.pdf IFNM, Institut Farmaseutikal & Nutraseutikal Malaysia (2017) A Study on the Potential of Active Constituent from Senna spectabilis in Treating Leishmania major Infection. IPHARM Newsletter, 1 (1). http://www.ipharm-nibm.my/newsletter.php
spellingShingle RM Therapeutics. Pharmacology
RS Pharmacy and materia medica
IFNM, Institut Farmaseutikal & Nutraseutikal Malaysia
A Study on the Potential of Active Constituent from Senna spectabilis in Treating Leishmania major Infection
title A Study on the Potential of Active Constituent from Senna spectabilis in Treating Leishmania major Infection
title_full A Study on the Potential of Active Constituent from Senna spectabilis in Treating Leishmania major Infection
title_fullStr A Study on the Potential of Active Constituent from Senna spectabilis in Treating Leishmania major Infection
title_full_unstemmed A Study on the Potential of Active Constituent from Senna spectabilis in Treating Leishmania major Infection
title_short A Study on the Potential of Active Constituent from Senna spectabilis in Treating Leishmania major Infection
title_sort study on the potential of active constituent from senna spectabilis in treating leishmania major infection
topic RM Therapeutics. Pharmacology
RS Pharmacy and materia medica
url http://eprints.usm.my/36440/
http://eprints.usm.my/36440/
http://eprints.usm.my/36440/1/c1edc42e7ecc26b5078b32919cba765b.pdf